Skip to main content
Erschienen in: Clinical Oral Investigations 9/2016

09.03.2016 | Original Article

Effect of alendronate on the progression of periodontitis induced by Porphyromonas gingivalis and Fusobacterium nucleatum: a study in rats

verfasst von: Carmen L. Mueller Storrer, Tatiana Miranda Deliberador, Allan Fernando Giovanini, Viviane Crivellaro, João Cesar Zielak, Giuseppe Alexandre Romito

Erschienen in: Clinical Oral Investigations | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

The study aimed to investigate the effect of alendronate (ALN) on the inhibition of alveolar bone loss in experimental periodontitis in Wistar rats.

Materials and methods

Periodontitis was induced by oral inoculation of Porphyromonas gingivalis with Fusobacterium nucleatum. The rats (n = 80) were randomized as follows: negative control (n = 10); positive control (n = 10); ALN groups: test 8 (n = 10), test 12 (n = 10), and test 16 (n = 10); and placebo groups: control 8 (n = 10), control 12 (n = 10), and control 16 (n = 10). Two milligrams per kilogram of ALN or placebo was administered twice weekly for 8, 12, and 16 weeks. Bone loss was determined by morphological and histological analyses. One independent, blinded examiner (ICC, 0.91) performed the measurements. The distance from the cement enamel junction to the alveolar bone crest of the second lower molar was measured: distal-vestibular (d), furca (f), mesial-vestibular (h), and area. Histometry was performed on the second contralateral molar. Sections (6 μm) were used to determine the furcation bone area (A-FB). The following statistical analyses were conducted: Mann-Whitney and Kruskal-Wallis.

Results

PC group developed periodontitis (p < 0.0001). Morphometric analysis determined that ALN was effective in T8 for linear measurements d, f, and h (p < 0.05). No significant differences occurred at test 8, test 12, and test 16. Analysis of A-FB revealed no significant differences between the ALN and placebo groups at 8 and 16 weeks (p > 0.05). ALN was effective against bone loss in relation to A-FB after 12 weeks (p < 0.0001).

Conclusions

According to the methodology used, the results suggest that oral administration of ALN could influence alveolar bone loss in rats submitted to experimental periodontitis.

Clinical relevance

ALN could be a potential therapeutic approach when associated with periodontal treatment.
Literatur
1.
Zurück zum Zitat Ito M, Amizuka N, Nakajima T, Ozawa H (1999) Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment. Bone 25:447–452CrossRefPubMed Ito M, Amizuka N, Nakajima T, Ozawa H (1999) Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment. Bone 25:447–452CrossRefPubMed
2.
Zurück zum Zitat Chun YH, Foster BL, Lukasavage PA, Berry JE, Zhao M, Tenenbaum HC, et al. (2005) Bisphosphonate modulates cementoblast behavior in vitro. J Periodontolol 76:1890–1900CrossRef Chun YH, Foster BL, Lukasavage PA, Berry JE, Zhao M, Tenenbaum HC, et al. (2005) Bisphosphonate modulates cementoblast behavior in vitro. J Periodontolol 76:1890–1900CrossRef
3.
Zurück zum Zitat Jeffcoat MK (2006) Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants 21:349–353PubMed Jeffcoat MK (2006) Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants 21:349–353PubMed
4.
Zurück zum Zitat Rodan GA (1998) Mechanism of action of bisphosphonates. Annu Rev Phamacol Toxicol 38:357–388 Rodan GA (1998) Mechanism of action of bisphosphonates. Annu Rev Phamacol Toxicol 38:357–388
5.
Zurück zum Zitat Brown DL, Robbins R (1999) Developments in the therapeutic applications of bisphosphonates. J Clin Pharmacol 39:651–660CrossRefPubMed Brown DL, Robbins R (1999) Developments in the therapeutic applications of bisphosphonates. J Clin Pharmacol 39:651–660CrossRefPubMed
6.
Zurück zum Zitat Yaffe A, Kollerman R, Bahar H, Binderman I (2003) The influence of alendronate on bone formation and resorption in a rat ectopic bone development model. J Periodontol 74:44–50CrossRefPubMed Yaffe A, Kollerman R, Bahar H, Binderman I (2003) The influence of alendronate on bone formation and resorption in a rat ectopic bone development model. J Periodontol 74:44–50CrossRefPubMed
7.
Zurück zum Zitat Black MD, Schwartz AV, Ensrud KE (2006) Effects on continuing stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extention (FLEX): a randomized trial. JAMA 296:2927–2938CrossRefPubMed Black MD, Schwartz AV, Ensrud KE (2006) Effects on continuing stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extention (FLEX): a randomized trial. JAMA 296:2927–2938CrossRefPubMed
9.
Zurück zum Zitat Fleisch H (1991) Bisphosphonates. Pharmacology and use in the treatment of tumor-induced hypercalcaemic and metastatic bone disease. Drugs 42:919–944CrossRefPubMed Fleisch H (1991) Bisphosphonates. Pharmacology and use in the treatment of tumor-induced hypercalcaemic and metastatic bone disease. Drugs 42:919–944CrossRefPubMed
10.
Zurück zum Zitat Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW (2000) Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer 82:1459–1468CrossRefPubMedPubMedCentral Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW (2000) Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer 82:1459–1468CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Williamson R (2010) Bisphosphonates and the dental practitioner—a guide to management. Ann R Australas Coll Dent Surg 20:46–9. Williamson R (2010) Bisphosphonates and the dental practitioner—a guide to management. Ann R Australas Coll Dent Surg 20:46–9.
12.
Zurück zum Zitat Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433–441CrossRefPubMed Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433–441CrossRefPubMed
13.
Zurück zum Zitat Aghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE, Bezouglaia O, Dry SM, Tetradis S (2011) Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res 26:1871–1882CrossRefPubMedPubMedCentral Aghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE, Bezouglaia O, Dry SM, Tetradis S (2011) Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res 26:1871–1882CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Sharma D, Ivanovski S, Slevin M, Hamlet S, Pop TS, Brinzaniuc K, Petcu EB, et al. (2013) Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect. Vascullar Cell 5:1–8CrossRef Sharma D, Ivanovski S, Slevin M, Hamlet S, Pop TS, Brinzaniuc K, Petcu EB, et al. (2013) Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect. Vascullar Cell 5:1–8CrossRef
15.
Zurück zum Zitat Brunsvold MA, Chaves SE, Kornman KS, Aufdemorte TB, Wood R (1992) Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 63:825–830CrossRefPubMed Brunsvold MA, Chaves SE, Kornman KS, Aufdemorte TB, Wood R (1992) Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 63:825–830CrossRefPubMed
16.
Zurück zum Zitat Tani-ishii N, Minamida G, Saitoh D, Chieda K, Omuro H, Sugaya A, et al. (2003) Inhibitory effects of incadronate on the progression of rat experimental periodontitis by Porphyromonas gingivalis infection. J Periodontol 74:603–609CrossRefPubMed Tani-ishii N, Minamida G, Saitoh D, Chieda K, Omuro H, Sugaya A, et al. (2003) Inhibitory effects of incadronate on the progression of rat experimental periodontitis by Porphyromonas gingivalis infection. J Periodontol 74:603–609CrossRefPubMed
17.
Zurück zum Zitat Meneses AM, Rocha FA, Chaves HV, Carvalho CB, Ribeiro RA, Brito GC (2005) Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats. J Periodontol 76:1901–1909CrossRef Meneses AM, Rocha FA, Chaves HV, Carvalho CB, Ribeiro RA, Brito GC (2005) Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats. J Periodontol 76:1901–1909CrossRef
18.
Zurück zum Zitat Spolidorio SC, Marcantonio E Jr, Spolidorio DMP, Nassar CA, Nassar PO, Marcantonio RA, et al. (2007) Alendronate therapy in cyclosporine-induced alveolar bone loss in rats. J Periodont Res 42:466–473CrossRefPubMed Spolidorio SC, Marcantonio E Jr, Spolidorio DMP, Nassar CA, Nassar PO, Marcantonio RA, et al. (2007) Alendronate therapy in cyclosporine-induced alveolar bone loss in rats. J Periodont Res 42:466–473CrossRefPubMed
19.
Zurück zum Zitat Jeffcoat MK, Cizza G, Shih WJ, Genco R, Lombardi A (2007) Efficacy of bisphosphonates for the control of alveolar bone in periodontitis. J Int Acad Periodontol 9:70–73PubMed Jeffcoat MK, Cizza G, Shih WJ, Genco R, Lombardi A (2007) Efficacy of bisphosphonates for the control of alveolar bone in periodontitis. J Int Acad Periodontol 9:70–73PubMed
20.
Zurück zum Zitat Shinoda H, Takeyama S, Suzuki K, Murakami S, Yamada S (2008) Pharmacological topics of bone metabolism: a novel bisphosphonate for the treatment of periodontitis. J Pharmacol Sci 106:555–558CrossRefPubMed Shinoda H, Takeyama S, Suzuki K, Murakami S, Yamada S (2008) Pharmacological topics of bone metabolism: a novel bisphosphonate for the treatment of periodontitis. J Pharmacol Sci 106:555–558CrossRefPubMed
21.
Zurück zum Zitat Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster J-Y, Borgstrom F, et al. (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399–428CrossRefPubMedPubMedCentral Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster J-Y, Borgstrom F, et al. (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399–428CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Gupta J, Gill AS, Sikri P (2011) Evaluation of the relative efficacy of an alloplast used alone and in conjunction with an osteoclast inhibitor in the treatment of human periodontal infrabony defects: a clinical and radiological study. Indian J Dent Res 22:225–231 Gupta J, Gill AS, Sikri P (2011) Evaluation of the relative efficacy of an alloplast used alone and in conjunction with an osteoclast inhibitor in the treatment of human periodontal infrabony defects: a clinical and radiological study. Indian J Dent Res 22:225–231
23.
Zurück zum Zitat Weinreb MQ, Quartuccio H, Seedor JG, Aufdemorte TB, Brunsvold M, Chaves E, et al. (1994) Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkey. J Periodontot Res 29:35–40CrossRef Weinreb MQ, Quartuccio H, Seedor JG, Aufdemorte TB, Brunsvold M, Chaves E, et al. (1994) Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkey. J Periodontot Res 29:35–40CrossRef
24.
Zurück zum Zitat Duarte P, De Assis DR, Casati MZ, Sallum AW, Sallum EA, Nociti FH Jr (2004) Alendronate may protect against increased periodontitis-related bone loss in estrogen-deficient rats. J Periodontol 75:1196–1202CrossRefPubMed Duarte P, De Assis DR, Casati MZ, Sallum AW, Sallum EA, Nociti FH Jr (2004) Alendronate may protect against increased periodontitis-related bone loss in estrogen-deficient rats. J Periodontol 75:1196–1202CrossRefPubMed
25.
Zurück zum Zitat Reddy MS, Weatherford TW 3rd, Smith CA, West BD, Jeffcoat MK, Jacks TM (1995) Alendronate treatment of naturally-occurring periodontitis in beagle dogs. J Periodontol 66:211–217CrossRefPubMed Reddy MS, Weatherford TW 3rd, Smith CA, West BD, Jeffcoat MK, Jacks TM (1995) Alendronate treatment of naturally-occurring periodontitis in beagle dogs. J Periodontol 66:211–217CrossRefPubMed
26.
Zurück zum Zitat Kesavalu L, Sathishkumar S, Bakthavatchalu V, Matthews C, Dawson D, Steffen M, et al. (2007) Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect Immun 75:1704–1712CrossRefPubMedPubMedCentral Kesavalu L, Sathishkumar S, Bakthavatchalu V, Matthews C, Dawson D, Steffen M, et al. (2007) Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect Immun 75:1704–1712CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Storrer CM, Aun CJ, Pustiglioni FE, Romito GA (2010) Periodontal disease induced by Porphyromonas gingivalis and Fusobacterium nucleatum in Wistar rats. Arq Odontol 46:185–189 Storrer CM, Aun CJ, Pustiglioni FE, Romito GA (2010) Periodontal disease induced by Porphyromonas gingivalis and Fusobacterium nucleatum in Wistar rats. Arq Odontol 46:185–189
28.
Zurück zum Zitat Duncan MJ (2005) Oral microbiology and genomics. Periodontol 2000(38):63–71CrossRef Duncan MJ (2005) Oral microbiology and genomics. Periodontol 2000(38):63–71CrossRef
29.
Zurück zum Zitat Rivaldo EG, Padilha DP, Hugo FN (2005) Alveolar bone loss and aging: a model for study in mice. J Periodontol 76:1966–1971CrossRefPubMed Rivaldo EG, Padilha DP, Hugo FN (2005) Alveolar bone loss and aging: a model for study in mice. J Periodontol 76:1966–1971CrossRefPubMed
30.
Zurück zum Zitat Kuhr A, Popa-Wagner A, Schmoll H, Schwahn C, Kocher T (2004) Observations on experimental marginal periodontitis in rats. J Periodontal Res 39:101–106CrossRefPubMed Kuhr A, Popa-Wagner A, Schmoll H, Schwahn C, Kocher T (2004) Observations on experimental marginal periodontitis in rats. J Periodontal Res 39:101–106CrossRefPubMed
31.
Zurück zum Zitat Deliberador TM, Nagata MJH, Furlaneto FAC, Melo LGN, Okamoto T, Sundefeld MM, et al. (2006) Autogenous bone graft with or without a calcium sulfate barrier in the treatment of class II furcation defects: a histologic and histometric study in dogs. J Periodontol 77:780–789CrossRefPubMed Deliberador TM, Nagata MJH, Furlaneto FAC, Melo LGN, Okamoto T, Sundefeld MM, et al. (2006) Autogenous bone graft with or without a calcium sulfate barrier in the treatment of class II furcation defects: a histologic and histometric study in dogs. J Periodontol 77:780–789CrossRefPubMed
32.
Zurück zum Zitat Baker J, Dixon M, Roopenian DC (2000) Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect Immunol 68:5864–5868CrossRef Baker J, Dixon M, Roopenian DC (2000) Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect Immunol 68:5864–5868CrossRef
33.
Zurück zum Zitat Zubery Y, Dunstan CR, Story BM, Kesavalu L, Ebersole JL, Holt SC, et al. (1998) Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin. Infect and Immun 66:4158–4162 Zubery Y, Dunstan CR, Story BM, Kesavalu L, Ebersole JL, Holt SC, et al. (1998) Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin. Infect and Immun 66:4158–4162
34.
Zurück zum Zitat Shoji K, Horiuchi H, Shinoda H (1995) Inhibitory effects of a bisphosphonate (risedronate) on experimental periodontitis in rats. J Periodontal Res 30:277–284CrossRefPubMed Shoji K, Horiuchi H, Shinoda H (1995) Inhibitory effects of a bisphosphonate (risedronate) on experimental periodontitis in rats. J Periodontal Res 30:277–284CrossRefPubMed
35.
Zurück zum Zitat Meulman T, Peruzzo DC, Stipp RN, Gonçalves PF, Sallum EA, Casati MZ, Goncalves RB, Nociti FH Jr (2011) Impact of Porphyromonas gingivalis inoculation on ligature-induced alveolar bone loss. A pilot study in rats. J Periodontal Res 46:629–636PubMed Meulman T, Peruzzo DC, Stipp RN, Gonçalves PF, Sallum EA, Casati MZ, Goncalves RB, Nociti FH Jr (2011) Impact of Porphyromonas gingivalis inoculation on ligature-induced alveolar bone loss. A pilot study in rats. J Periodontal Res 46:629–636PubMed
36.
Zurück zum Zitat Rossini M, Gatti D, Zamberlan N, Braga V, Dorrizi R, Adami S (1994) Long-term effect of treatment course with oral alendronate of postmenopausal osteoporosis. J Bone Miner Res 9:1833–1837CrossRefPubMed Rossini M, Gatti D, Zamberlan N, Braga V, Dorrizi R, Adami S (1994) Long-term effect of treatment course with oral alendronate of postmenopausal osteoporosis. J Bone Miner Res 9:1833–1837CrossRefPubMed
37.
Zurück zum Zitat Giuliani N, Pedrazzoni M, Passeri G, Girasole G (1998) Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scand J Rheumatol 27:38–41CrossRefPubMed Giuliani N, Pedrazzoni M, Passeri G, Girasole G (1998) Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scand J Rheumatol 27:38–41CrossRefPubMed
38.
Zurück zum Zitat Crawford JM, Taubman MA, Smith DJ (1978) The natural history of periodontal bone loss in germfree and gnotobiotic rats infected with periodontopathic microorganisms. J Periodontol Res 13:316–325CrossRef Crawford JM, Taubman MA, Smith DJ (1978) The natural history of periodontal bone loss in germfree and gnotobiotic rats infected with periodontopathic microorganisms. J Periodontol Res 13:316–325CrossRef
39.
Zurück zum Zitat Klausen B, Evans RT, Sfintescu C (1989) Two complementary methods of assessing periodontal bone level in rats. Scand J Dent Res 97:494–499PubMed Klausen B, Evans RT, Sfintescu C (1989) Two complementary methods of assessing periodontal bone level in rats. Scand J Dent Res 97:494–499PubMed
40.
Zurück zum Zitat Alencar VBM, Bezerra MM, Lima V, Abreu ALC, Brito GAC, Rocha FAC, et al. (2002) Disodium chlodronate prevents bone resorption in experimental periodontitis in rats. J Periodontol 73:251–256CrossRefPubMed Alencar VBM, Bezerra MM, Lima V, Abreu ALC, Brito GAC, Rocha FAC, et al. (2002) Disodium chlodronate prevents bone resorption in experimental periodontitis in rats. J Periodontol 73:251–256CrossRefPubMed
41.
Zurück zum Zitat Holt SC, Ebersole JL (2005) Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000(38):78–122 Holt SC, Ebersole JL (2005) Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000(38):78–122
42.
Zurück zum Zitat Tipton DA, Seshul BA, Dabbous MK (2011) Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. J Periodont Res 46:39–47CrossRefPubMed Tipton DA, Seshul BA, Dabbous MK (2011) Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. J Periodont Res 46:39–47CrossRefPubMed
43.
Zurück zum Zitat Moreira MM, Bradaschia-Correa V, Marques ND, Ferreira LB, Arana-Chavez VE (2014) Ultrastructural and immunohistochemical study of the effect of sodium alendronate in the progression of experimental periodontitis in rats. Microsc Res Tech 77:902–909CrossRefPubMed Moreira MM, Bradaschia-Correa V, Marques ND, Ferreira LB, Arana-Chavez VE (2014) Ultrastructural and immunohistochemical study of the effect of sodium alendronate in the progression of experimental periodontitis in rats. Microsc Res Tech 77:902–909CrossRefPubMed
Metadaten
Titel
Effect of alendronate on the progression of periodontitis induced by Porphyromonas gingivalis and Fusobacterium nucleatum: a study in rats
verfasst von
Carmen L. Mueller Storrer
Tatiana Miranda Deliberador
Allan Fernando Giovanini
Viviane Crivellaro
João Cesar Zielak
Giuseppe Alexandre Romito
Publikationsdatum
09.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 9/2016
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-016-1769-4

Weitere Artikel der Ausgabe 9/2016

Clinical Oral Investigations 9/2016 Zur Ausgabe

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.